SHREE GANESH REMEDIES
Back to Balance Sheet
|
SHREE GANESH REMEDIES Last 5 Year Total Non-Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹30 Cr | ₹31 Cr | ₹0.40 Cr | ₹0.41 Cr | ₹0.50 Cr |
What is the latest Total Non-Current Liabilities ratio of SHREE GANESH REMEDIES ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹30 Cr |
Mar2023 | ₹31 Cr |
Mar2022 | ₹0.40 Cr |
Mar2021 | ₹0.41 Cr |
Mar2020 | ₹0.50 Cr |
How is Total Non-Current Liabilities of SHREE GANESH REMEDIES Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹30 Cr | -1.37 | |
Mar2023 | ₹31 Cr | 7,505.72 | |
Mar2022 | ₹0.40 Cr | -1.23 | |
Mar2021 | ₹0.41 Cr | -17.78 | |
Mar2020 | ₹0.50 Cr | - |
Compare Total Non-Current Liabilities of peers of SHREE GANESH REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SHREE GANESH REMEDIES | ₹879.0 Cr | -5.1% | 2.4% | 1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹433,920.0 Cr | -0.1% | 1.7% | 45.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,160.0 Cr | -0.1% | -2.2% | 56.9% | Stock Analytics | |
CIPLA | ₹118,917.0 Cr | 1.7% | 0.5% | 23.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,017.0 Cr | 5.7% | 12.4% | 18.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,997.1 Cr | -1.4% | 3.1% | 44.8% | Stock Analytics |
SHREE GANESH REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SHREE GANESH REMEDIES | -5.1% |
2.4% |
1% |
SENSEX | -5% |
0.6% |
9.2% |
You may also like the below Video Courses